These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 34504784)

  • 1. A Competing Risk Nomogram for Predicting Cancer-Specific Death of Patients With Maxillary Sinus Carcinoma.
    Hu M; Li X; Gu W; Mei J; Liu D; Chen S
    Front Oncol; 2021; 11():698955. PubMed ID: 34504784
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nomogram Predicting Cancer-Specific Death in Parotid Carcinoma: a Competing Risk Analysis.
    Li X; Hu M; Gu W; Liu D; Mei J; Chen S
    Front Oncol; 2021; 11():698870. PubMed ID: 34722245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A competing risk nomogram for predicting cancer-specific death of patients with buccal mucosa cancer.
    Jiang Q; Xue D; Xin Y; Qiu J
    Oral Dis; 2021 May; 27(4):900-910. PubMed ID: 32791562
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Developing and validating a novel nomogram used a competing-risks model for predicting the prognosis of primary fallopian tube carcinoma: a retrospective study based on the SEER database.
    Li C; Li J; Huang Q; Feng X; Zhao F; Xu F; Han D; Lyu J
    Ann Transl Med; 2021 Mar; 9(5):378. PubMed ID: 33842599
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A competing-risk nomogram to predict cause-specific death in elderly patients with colorectal cancer after surgery (especially for colon cancer).
    Wang Z; Wang Y; Yang Y; Luo Y; Liu J; Xu Y; Liu X
    World J Surg Oncol; 2020 Feb; 18(1):30. PubMed ID: 32019568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nomogram to Predict Cause-Specific Mortality in Patients With Surgically Resected Stage I Non-Small-Cell Lung Cancer: A Competing Risk Analysis.
    Zhou H; Zhang Y; Qiu Z; Chen G; Hong S; Chen X; Zhang Z; Huang Y; Zhang L
    Clin Lung Cancer; 2018 Mar; 19(2):e195-e203. PubMed ID: 29153966
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A competing risk nomogram predicting cause-specific mortality in patients with lung adenosquamous carcinoma.
    Wu X; Yu W; Petersen RH; Sheng H; Wang Y; Lv W; Hu J
    BMC Cancer; 2020 May; 20(1):429. PubMed ID: 32416716
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Competing-risks nomogram for predicting cancer-specific death in upper tract urothelial carcinoma: a population-based analysis.
    Li C; Han D; Huang Q; Xu F; Zheng S; Li X; Zhao F; Feng X; Lyu J
    BMJ Open; 2021 Jul; 11(7):e048243. PubMed ID: 34281927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Competing-risk nomogram for predicting survival in patients with advanced (stage III/IV) gallbladder cancer: A SEER population-based study.
    Wang J; Yang Y; Pan J; Qiu Y; Shen S; Wang W
    Jpn J Clin Oncol; 2022 Apr; 52(4):353-361. PubMed ID: 35137118
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Competing-Risks Nomogram in Patients with Metastatic Pancreatic Duct Adenocarcinoma.
    Lu Y; Zhou Y; Cao Y; Shi Z; Meng Q
    Med Sci Monit; 2019 May; 25():3683-3691. PubMed ID: 31102397
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel model to predict cancer-specific survival in patients with early-stage uterine papillary serous carcinoma (UPSC).
    Chen L; Liu X; Li M; Wang S; Zhou H; Liu L; Cheng X
    Cancer Med; 2020 Feb; 9(3):988-998. PubMed ID: 31846222
    [TBL] [Abstract][Full Text] [Related]  

  • 12. De-escalating chemotherapy for stage I-II gastric neuroendocrine carcinoma? A real-world competing risk analysis.
    Du D; Xie Y; Li X; Ni Z; Shi J; Huang H
    World J Surg Oncol; 2023 May; 21(1):142. PubMed ID: 37149679
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Establishment of a Competing Risk Nomogram in Patients with Pulmonary Sarcomatoid Carcinoma.
    Liang Z; Zhang E; Duan L; Weygant N; An G; Hu B; Yao J
    Technol Cancer Res Treat; 2022; 21():15330338211068960. PubMed ID: 35179409
    [No Abstract]   [Full Text] [Related]  

  • 14. Melanoma-specific mortality and competing mortality in patients with non-metastatic malignant melanoma: a population-based analysis.
    Shen W; Sakamoto N; Yang L
    BMC Cancer; 2016 Jul; 16():413. PubMed ID: 27389173
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Competing-risks nomograms for predicting cause-specific mortality in parotid-gland carcinoma: A population-based analysis.
    Xu F; Feng X; Zhao F; Huang Q; Han D; Li C; Zheng S; Lyu J
    Cancer Med; 2021 Jun; 10(11):3756-3769. PubMed ID: 33960711
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Outcomes in the Patients With Colorectal Cancer: A Multi-Registry-Based Cohort Study of 197,699 Cases in the Real World.
    Zhang S; Wang Y; Zhang P; Ai L; Liu T
    Front Cardiovasc Med; 2022; 9():851833. PubMed ID: 35783821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Competing Risk-based Prognostic Model to Predict Cancer-specific Death of Patients with Spinal and Pelvic Chondrosarcoma.
    Dong Y; Xie L; Kang H; Peng R; Guo Q; Song K; Wang J; Guan H; Fang Z; Li F
    Spine (Phila Pa 1976); 2021 Nov; 46(22):E1192-E1201. PubMed ID: 34714793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nomograms for Estimating Cause-Specific Death Rates of Patients With Inflammatory Breast Cancer: A Competing-Risks Analysis.
    Xu F; Yang J; Han D; Huang Q; Li C; Zheng S; Wang H; Lyu J
    Technol Cancer Res Treat; 2021; 20():15330338211016371. PubMed ID: 34013802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Model to Predict Cause-Specific Mortality in Patients with Head and Neck Adenoid Cystic Carcinoma: A Competing Risk Analysis.
    Shen W; Sakamoto N; Yang L
    Ann Surg Oncol; 2017 Aug; 24(8):2129-2136. PubMed ID: 28424937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and Validation of Nomograms for Predicting Cancer-Specific Survival in Elderly Patients with Intrahepatic Cholangiocarcinoma After Liver Resection: A Competing Risk Analysis.
    Wang T; Zhang J; Wang W; Yang X; Kong J; Shen S; Wang W
    Cancer Manag Res; 2020; 12():11015-11029. PubMed ID: 33173335
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.